Lusayan, Peah P.
HRN: 22-40-74 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/01/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
11/01/2023
11/07/2023
IVT
4.5gms
Q6
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes